Remove Article Remove COVID-19 Vaccine Remove Public Health Remove World Health
article thumbnail

Human Rights Principles in Public Health Emergencies: From the Siracusa Principles to COVID-19 and Beyond

Bill of Health

Extensive abuses of human rights during the pandemic led international experts to draft the Principles and Guidelines on Human Rights and Public Health Emergencies (HR Principles). The inadequacy of Siracusa in the the context of public health emergencies Then came COVID-19.

COVID-19 284
article thumbnail

What the New York City Marathon Can Teach Us About Equitable Access to Vaccines

Bill of Health

By Ana Santos Rutschman What can the New York City Marathon experience teach those reflecting on ways to increase equity in the transnational allocation of scarce vaccine doses? Vaccines are pharmaceutical products, a critical tool in public and global health. Quite a lot, it turns out.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Using Contracts to Lessen Inequities in Access to Medicines in Pandemics and Epidemics

Bill of Health

Research funding contracts can help to safeguard against profound inequities in global allocation and distribution of lifesaving diagnostics, drugs, and vaccines. During large transnational public health crises, global demand soars for diagnostics, drugs, and vaccines. We summarize our proposals in the following sections.

article thumbnail

Data Lights the Path Toward Ethical COVID-19 Vaccination Distribution

Healthcare IT Today

The following is a guest article by Kurt Waltenbaugh, CEO at Carrot Health.

article thumbnail

Making Explicit a Rights-Based Approach to Infodemic in a Public Health Emergency

Bill of Health

By Calvin Wai-Loon Ho With the mainstreaming of digital technology across many spheres of social life, infodemic management must be an integral part of public health emergency prevention, preparedness, response, and recovery.

article thumbnail

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill of Health

Monsanto and Myriad) ( this 2015 article discusses the history and taxonomy of patent pledges, many of which are collected in this online database ). In short, these public statements, if made in a manner that is intended to be taken seriously (e.g., Licensing structures like this go back at least to World War II, when the U.S.

article thumbnail

SQA Regulatory Surveillance Summary 3 | Monthly Update 2021

SQA

Commission Extends Transparency and Authorization Mechanism for Exports of COVID-19 Vaccines, 11 March 2021. The EC has extended until the end of June 2021 the transparency and authorization mechanism for COVID-19 vaccine exports. The EU continues to be the leading provider of vaccines around the world.